Navigation Links
Bionovo Announces Third Quarter 2010 Highlights and Financial Results
Date:11/11/2010

and Bezielle programs, for menopausal symptom alleviation and the treatment of advanced breast cancer, respectively, or about $489,000."We are extremely pleased that our programs for Menerba and Bezielle have been reviewed and assessed favorably by the federal government resulting in two grants under the QTDP grant program, both grants at the maximum level available," said Isaac Cohen, Bionovo's Chairman and Chief Executive Officer.


  • The Company announced the publication of a review of results from studies discussing new classes of estrogen receptor modulating drugs with distinct mechanism for pharmacological effect. The review outlines Bionovo's platform of estrogen receptor modulators for conditions associated with menopause, such as hot flashes, menopausal obesity and metabolic syndrome."Bionovo's platform for the discovery of unique drugs for women's health and cancer is described in this review. We now know we can selectively regulate estrogen receptors for specific indications that have a better safety profile. This opens the door for new treatments for many afflictions women encounter after menopause," said Dr. Cohen.


  • The Company announced that it had raised approximately $3.0 million in gross proceeds in a registered direct offering through the sale of common stock and warrants.Third Quarter ResultsFor the quarter ending September 30, 2010 total revenue was $68,000 compared with $155,000 for the same period in 2009. The revenue received in the third quarter of 2010 was received under a National Institutes of Health ("NIH") grant that began in the third quarter of 2010.  The revenue received during the same period of 2009 was received under an NIH grant that expired in 2009.

    Total operating expenses for the three months ending September 30, 2010 were $4.7 million compared to $3.9 million for the same period in 2009 and $4.1 million for the second quarter of 2010.  To
    '/>"/>


  • SOURCE Bionovo, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. Bionovo, Inc. to Announce Third Quarter Fiscal Year 2010 Financial Results on Thursday, November 11, 2010
    2. Bionovo Announces Publication Describing Potential Estrogen Receptor Modulating Drugs for Treating Menopausal Conditions
    3. Bionovo to Raise $3 Million Through Registered Direct Offering
    4. Bionovo to Present at the JMP Securities Healthcare Conference
    5. Bionovo to Present at Cambria Capital Investor Meeting
    6. Bionovo Receives Positive Guidance from FDA on Menerba®
    7. Bionovo Announces Reverse Stock Split
    8. Bionovo Announces Publication Describing Menerbas Effect on Neural Pathways Related to Temperature Regulation
    9. Bionovo to Advance Menerba to Phase 3 Clinical Testing in Europe
    10. Bionovo, Inc. to Announce Second Quarter Fiscal Year 2010 Financial Results on Wednesday, August 4, 2010
    11. Bionovo Announces a $15 Million At-The-Market Firm Commitment Financing Agreement
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/24/2014)... , December 24, 2014 ... on Global Disposable Syringe Industry of 178 ... online business intelligence library. The ... Syringe Industry is a professional and deep ...  For overview analysis, the report introduces Disposable ...
    (Date:12/24/2014)... , Dec. 23, 2014 Tianyin Pharmaceutical ... that specializes in patented biopharmaceutical, modernized traditional Chinese ... (API) today announced that the Company achieved the ... Manufacturing Practice (GMP) certificate of TPI,s Qionglai Facility ... (CFDA). The public notice period is a significant ...
    (Date:12/22/2014)... LAWRENCE, Mass. , Dec. 22, 2014 /PRNewswire/ ... a leading manufacturer of innovative dialysis products, announced ... (FDA) has cleared its System One™ to perform ... sleeping, known as home nocturnal hemodialysis. NxStage,s® System ... cleared by the FDA for this indication. ...
    Breaking Medicine Technology:World Disposable Syringe Market 2014 Report: China and Regional Analysis 2World Disposable Syringe Market 2014 Report: China and Regional Analysis 3World Disposable Syringe Market 2014 Report: China and Regional Analysis 4World Disposable Syringe Market 2014 Report: China and Regional Analysis 5TPI QLF Achieved Public Notice Status of GMP Certification 2TPI QLF Achieved Public Notice Status of GMP Certification 3NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 2NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 3
    ... than 11,000 churches since,its launch in April, ... In preparation for flu,season, The COSHAR Foundation ... vaccine-preventable illnesses -- including the flu. The,Foundation,s ... awareness,campaign, Protecting our Future: The COSHAR Foundation ...
    ... 10 Raptor,Pharmaceuticals Corp. ("Raptor" or the ... the Company has entered into an agreement ... of France to,evaluate Raptor,s proprietary delayed-release cysteamine ... trial in patients with Huntington,s,Disease ("Huntington,s"). CHU ...
    Cached Medicine Technology:The COSHAR Foundation Urges Parents to Ensure Children Are Up-to-Date on Vaccinations 2Raptor Pharmaceuticals to Collaborate with Centre Hospitalier Universitaire d'Angers for Phase II Clinical Trial in Huntington's Disease 2Raptor Pharmaceuticals to Collaborate with Centre Hospitalier Universitaire d'Angers for Phase II Clinical Trial in Huntington's Disease 3Raptor Pharmaceuticals to Collaborate with Centre Hospitalier Universitaire d'Angers for Phase II Clinical Trial in Huntington's Disease 4Raptor Pharmaceuticals to Collaborate with Centre Hospitalier Universitaire d'Angers for Phase II Clinical Trial in Huntington's Disease 5Raptor Pharmaceuticals to Collaborate with Centre Hospitalier Universitaire d'Angers for Phase II Clinical Trial in Huntington's Disease 6
    (Date:12/26/2014)... Plugin and template developers from Pixel Film ... Final Cut Pro X. , “TransPack Volume 5 gives users ... off an industry professional look” Said Christina Austin, CEO of ... Volume 5, a new level of professionalism will become the ... 50 Final Cut Pro X transitions featuring organic animations. Choose ...
    (Date:12/26/2014)... December 26, 2014 DW-InductionHeating.com (DaWei Induction ... designing, researching and developing, producing and marketing of a ... the business announces their new series of induction ... of the company, induction brazing refers to ... special filler material and heat. The manager says that ...
    (Date:12/25/2014)... The click strand woven ... and durability. Today, the business announces a click ... until Jan. 30, 2015. , Click strand woven ... BambooFlooringChina.com is a well-known brand in the bamboo ... find a reliable bamboo flooring supplier. , “We ...
    (Date:12/25/2014)... 2014 “Every three months the trends for ... sweetheart evening dress will be one of the hottest styles ... Yunx.co.uk says. Today, the company releases 26 A-line sweetheart evening ... 80% off. , “We are trying our best to ... our latest designs. Along with affordable prices, we provide discounted ...
    (Date:12/25/2014)... Recently, BellasDress has launched ... wedding dresses. BellasDress has chosen their best-selling lace wedding ... for the holiday season. , Now, BellasDress.com features ... gowns here at discount prices. The business hopes everyone ... website. , “All our elegant products are ...
    Breaking Medicine News(10 mins):Health News:Today a new plugin was announced from Pixel Film Studios, TransPack Volume 5 for Final Cut Pro X 2Health News:Induction Brazing Equipment Series From DaWei Induction Heating Co., A Reliable Supplier Of Induction Heating Equipment 2Health News:BambooFlooringChina.com: click strand woven bamboo flooring promotion valid until Jan. 30, 2015. 2Health News:BellasDress.com’s Christmas Sale: Trendy Wedding Dresses With Big Discounts 2
    ... SINGAPORE, Oct. 31 Flextronics International,Ltd. (Nasdaq: ... Flextronics,s,previously announced acquisition of Solectron Corporation on October ... 0.50% Convertible,Senior Notes due 2034 (CUSIP Nos. 834182 ... Convertible Senior Notes Series B due 2034 (CUSIP ...
    ... Impact,Medical Solutions, Inc. (OTC Bulletin Board: IMSU), ... Craig W. Lunsman to its board,of directors. Mr. ... William,Jamieson Group, LLC, a consulting group that provides ... private small cap companies.,As an outside director, Mr. ...
    ... PETA Talking Points, Discourages Donations to,Legitimate Cancer Charities, ... today,s report on global causes of cancer from ... for Consumer Freedom is urging,them to be skeptical ... calling itself "The Cancer Project." A project of ...
    ... data finds no link to most common illnesses , ... do not increase the risk of cancers, connective tissue ... researchers. , A team from the International Epidemiology Institute ... in Nashville, Tenn., reviewed available research on the safety ...
    ... UCLA and Vanderbilt football coach Red Sanders, I just want ... 15-year-old athlete, New research indicates that young athletes find playing ... maximum effort is far more important and has a bigger ... terms of athletes ratings of how much fun they had ...
    ... Oct. 31 Every day that goes,by without progress ... wasted, and more damage is done to an already,weakened ... pro tem introduced their health reform plans at the ... a vigorous debate that,finally would result in health coverage ...
    Cached Medicine News:Health News:Flextronics Announces Change in Control Repurchase Offer for Solectron's 0.50% Senior Convertible Notes 2Health News:Impact Medical Solutions Announces Appointment of New Director 2Health News:Impact Medical Solutions Announces Appointment of New Director 3Health News:Consumer Alert: 'Cancer Project' Organization Is a Deceptive Animal Rights Group 2Health News:Little Evidence Silicone Breast Implants Harm Health 2Health News:Motivational coaching climate outscores winning for young athletes 2Health News:Statement by Bruce Bodaken, Chairman & CEO, Blue Shield of California 2
    ...
    ...
    EDM Ventricular Drainage Kit, with Drip Chamber with and without Bioglide are fabricated of radiopaque (barium impregnated) silicone tubing, and are packaged with stainless steel stylets inserted in ...
    Medtronic neurosurgery external drainage and monitoring (EDM) products meet a variety of needs for CSF drainage and monitoring....
    Medicine Products: